Cargando…

Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2020
Materias:	Corrections
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607867/ https://www.ncbi.nlm.nih.gov/pubmed/33144278 http://dx.doi.org/10.1136/bmj.m4232

Ejemplares similares

Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)
por: Agarwal, Anup, et al.
Publicado: (2020)

Correction to: A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial
por: Devos, Timothy, et al.
Publicado: (2020)

Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial
por: Sekine, Leo, et al.
Publicado: (2022)

Author Correction: Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
por: Bégin, Philippe, et al.
Publicado: (2022)

Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients—An Open-Label Phase II Clinical Trial
por: Grubovic Rastvorceva, Rada M., et al.
Publicado: (2022)

A multicentre randomised controlled trial evaluating lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea in older people admitted to hospital: the PLACIDE study protocol
por: Allen, Stephen J, et al.
Publicado: (2012)

A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19
por: Ray, Yogiraj, et al.
Publicado: (2022)

A l'ouest de Lake Placid : roman /
por: Goeldlin, Michel, 1934-
Publicado: (1979)

Placides et Timéo ou Li secrés as philosophes
por: Nutton, Vivian
Publicado: (1983)

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Publicado: (2021)

Correction: Haemostasis treatment using dual red imaging during endoscopic submucosal dissection: a multicentre, open-label, randomised controlled trial
Publicado: (2019)

Convalescent Plasma Therapy in Critically Ill COVID-19 Patients: An Open Label Trial
por: Khamis, Faryal, et al.
Publicado: (2021)

Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
por: Bégin, Philippe, et al.
Publicado: (2021)

Correction To: Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial
por: Qin, Shukui, et al.
Publicado: (2022)

Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial
por: Bégin, Philippe, et al.
Publicado: (2021)

Nutritional route in oesophageal resection trial II (NUTRIENT II): study protocol for a multicentre open-label randomised controlled trial
por: Berkelmans, Gijs H K, et al.
Publicado: (2016)

Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study
por: Beigel, John H, et al.
Publicado: (2017)

Correction: Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks’ gestation (HYPITAT-II): a multicentre, open-label randomised controlled trial
por: Broekhuijsen, Kim, et al.
Publicado: (2013)

Efficacy of convalescent plasma therapy for COVID-19 in Japan: An open-label, randomized, controlled trial
por: Saito, Sho, et al.
Publicado: (2023)

Inased (inhaled sedation in ICU) trial protocol: a multicentre randomised open-label trial
por: Bailly, Pierre, et al.
Publicado: (2021)

Convalescent plasma for treatment of COVID-19: study protocol for an open randomised controlled trial in Sweden
por: Dillner, Joakim, et al.
Publicado: (2021)

Efficacy of convalescent plasma therapy in the patient with COVID-19: a randomised control trial (COPLA-II trial)
por: Bajpai, Meenu, et al.
Publicado: (2022)

A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial
por: Devos, Timothy, et al.
Publicado: (2020)

Correction: Multicentre, randomised, open-label, non-inferiority trial comparing the effectiveness and safety of ductal lavage versus oral corticosteroids for idiopathic granulomatous mastitis: a study protocol
Publicado: (2022)

A Phase II trial of Higher RadiOtherapy Dose In The Eradication of early rectal cancer (APHRODITE): protocol for a multicentre, open-label randomised controlled trial
por: Hudson, Eleanor M, et al.
Publicado: (2022)

Induction of labour at 41 weeks versus expectant management and induction of labour at 42 weeks (SWEdish Post-term Induction Study, SWEPIS): multicentre, open label, randomised, superiority trial
Publicado: (2021)

Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL): a multicentre, open-label, randomised, controlled phase II trial
por: Urbonas, V, et al.
Publicado: (2019)

Financial incentives for smoking cessation in pregnancy: multicentre randomised controlled trial
Publicado: (2021)

Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial
por: Lacombe, Karine, et al.
Publicado: (2023)

Rationale and design of the PLACID study: a randomised trial comparing the efficacy and safety of inhaled loxapine versus IM aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder
por: San, L., et al.
Publicado: (2017)

Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial
por: Soin, Arvinder S, et al.
Publicado: (2021)

Palliative radiotherapy after oesophageal cancer stenting (ROCS): a multicentre, open-label, phase 3 randomised controlled trial
por: Adamson, Douglas, et al.
Publicado: (2021)

Shunting outcomes in communicating hydrocephalus: protocol for a multicentre, open-label, randomised controlled trial
por: Sun, Tong, et al.
Publicado: (2021)

Primary trabeculectomy for advanced glaucoma: pragmatic multicentre randomised controlled trial (TAGS)
Publicado: (2021)

Primary trabeculectomy for advanced glaucoma: pragmatic multicentre randomised controlled trial (TAGS)
Publicado: (2021)

PTPRZ1-METFUsion GENe (ZM-FUGEN) trial: study protocol for a multicentric, randomized, open-label phase II/III trial
por: Bao, Zhaoshi, et al.
Publicado: (2023)

Sarcome-13/OS2016 trial protocol: a multicentre, randomised, open-label, phase II trial of mifamurtide combined with postoperative chemotherapy for patients with newly diagnosed high-risk osteosarcoma
por: Brard, Caroline, et al.
Publicado: (2019)

Bevacizumab versus placebo in combination with paclitaxel and carboplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase II trial
por: Zhou, T., et al.
Publicado: (2021)

Correction: Induction of labour with a Foley catheter or oral misoprostol at term: the PROBAAT-II study, a multicentre randomised controlled trial
por: ten Eikelder, Mieke LG, et al.
Publicado: (2013)

Author Correction: An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients
por: Ravichandran, Rajan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b7db5arpe2jrjjajt2b7fns1et